Biotech News

Pennant Reports First Quarter 2026 Results

Pennant Group (PNTG)Pennant Group2026-05-06 20:05 ESTEarnings

Conference Call and Webcast scheduled for tomorrow, May 7, 2026 at 10:00 am MT EAGLE, Idaho, May 06, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating

Open original release

Related news

PNTGPennant Group2026-06-04 15:16 EST

The Pennant Group and Hartford HealthCare Expand Collaboration to Advance Home-Based Care in Connecticut

PNTGPennant Group2026-06-03 11:00 EST

Pennant Expands Senior Living Presence with Pleasant Hill, California Community

PNTGPennant Group2026-05-18 22:03 EST

Pennant Group to Participate in the 2026 RBC Global Healthcare Conference

PNTGPennant Group2026-05-18 21:22 EST

Pennant Announces an Acquisition of Senior Living Community in Arizona

PNTGPennant Group2026-05-04 23:34 EST

Pennant Announces First Quarter 2026 Earnings Release and Call

PNTGPennant Group2026-05-01 22:28 EST

Pennant Acquires Senior Living Communities in Arizona and Wisconsin

PNTGPennant Group2026-04-01 20:53 EST

Pennant Acquires Arbor Rose Senior Living Community in Mesa, Arizona

PNTGPennant Group2026-03-17 17:40 EST

UPDATE – Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference

PNTGPennant Group2026-03-16 22:15 EST

Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference

PNTGPennant Group2026-02-25 21:25 EST

Pennant Reports Fourth Quarter and Fiscal Year 2025 Results

View all latest news

Pennant Group

The Pennant Group is a healthcare services company focused on home health, hospice, and senior-care operations. Its business is centered on post-acute care delivery rather than biotech or devices.

Recent company news

PNTGBruker2026-07-24 20:01 EST

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

PNTGQuest Diagnostics2026-07-23 10:45 EST

Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

PNTGMolina Healthcare2026-07-22 20:15 EST

Molina Healthcare Reports Second Quarter 2026 Financial Results

PNTGAxon Enterprise, Inc.2026-07-22 20:01 EST

Axon to Release Second Quarter 2026 Earnings on August 5, 2026

PNTGGSK plc2026-07-22 11:21 EST

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

Stock data

Close: 39.81 USD
Market cap: 1.07B USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States